Susquehanna International Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50,128
| Closed | -$5.38M | – | 6803 |
|
|
2023
Q1 | $5.38M | Buy |
50,128
+43,823
| +695% | +$4.7M | ﹤0.01% | 1073 |
|
|
2022
Q4 | $694K | Sell |
6,305
-33,956
| -84% | -$3.74M | ﹤0.01% | 2775 |
|
|
2022
Q3 | $2.38M | Buy |
40,261
+27,612
| +218% | +$1.63M | ﹤0.01% | 1508 |
|
|
2022
Q2 | $357K | Buy |
12,649
+1,161
| +10% | +$32.8K | ﹤0.01% | 3766 |
|
|
2022
Q1 | $434K | Buy |
+11,488
| New | +$434K | ﹤0.01% | 3879 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6657 |
|